To embed, copy and paste the code into your website or blog:
On February 24, 2021, DOJ’s Criminal Division Fraud Section published its annual year-end summary (available here). The Fraud Section focuses on prosecuting white-collar crime. The report summarizes enforcement activity in the past year and discusses notable cases from the Fraud Section’s three litigation units: (1) the Health Care Fraud (HCF) Unit; (2) the Foreign Corrupt Practices Act (FCPA) Unit; and (3) the Market Integrity and Major Frauds (MIMF) Unit. In summarizing the Fraud Section’s main achievements from 2020, the report also provides valuable insights on what lies ahead for the Fraud Section in 2021. This post focuses on the health care enforcement portion of the Fraud Section’s report.
Who Needs to Know
Why It Matters
As evidenced in the recently published 2020 Year in Review Report (Report), the Department of Justice’s Fraud Section (Fraud Section) demonstrated its resilience despite the COVID-19 pandemic, as well as its swift response to the evolution of pandemic-induced fraud a trend we expect will continue throughout 2021.
As evidenced in the recently published 2020 Year in Review Report (Report), the Department of Justice’s Fraud Section (Fraud Section) demonstrated its resilience despite the COVID-19 pandemic, as well as its swift response to the evolution of pandemic-induced fraud a trend we expect will continue throughout 2021.
Several areas of COVID-19-related fraud have emerged throughout the past year the most prominent associated with personal protective equipment (PPE), COVID-19 testing, and the Paycheck Protection Program (PPP) which DOJ has successfully prosecuted under price gouging, health care, and securities fraud laws.
Monday, March 8, 2021
On February 24, 2021, DOJ’s Criminal Division Fraud Section published its annual year-end summary (available here). The Fraud Section focuses on prosecuting white-collar crime. The report summarizes enforcement activity in the past year and discusses notable cases from the Fraud Section’s three litigation units: (1) the Health Care Fraud (HCF) Unit; (2) the Foreign Corrupt Practices Act (FCPA) Unit; and (3) the Market Integrity and Major Frauds (MIMF) Unit. In summarizing the Fraud Section’s main achievements from 2020, the report also provides valuable insights on what lies ahead for the Fraud Section in 2021. This post focuses on the health care enforcement portion of the Fraud Section’s report.
Note from the Editors
Digital technologies have transformed almost every aspect of the health care and life sciences industry from electronic health records and telemedicine, to diagnostics and therapeutics augmented by artificial intelligence, and to remote clinical trials. The year 2020 witnessed the COVID-19 pandemic catalyzing unprecedented levels of digital health innovation and adoption. The digital health industry is entering 2021 with optimism for even greater advancement, reductions in regulatory burdens, and continued widespread adoption of digital health technologies. In the Industry Insights contribution for this issue, several of our digital health experts briefly summarize the major advancements in four key digital health areas that took place over 2020, as well as expectations for 2021.